Where
Medicine Begins

Help Improve Lives.
Enjoy the Experience.

Get Early Access to New Medicines

Clinical studies offer more care options for patients suffering from common, unique, and rare health conditions.

Help Move Science Forward

Clinical studies offer a way for almost anyone — regardless of their background — to help improve human health and wellbeing.

Receive Compensation if You Qualify

Most Meridian studies offer payment for time and travel. We'll let you know what to expect during your first phone call with Meridian.

Give Hope to People Worldwide

Clinical trials offer hope for many people and an opportunity to help researchers find better treatments for others in the future.

Do I need insurance to join a study?

Will I be paid for my time?

What are the potential benefits or risks?

How long does a study last?

Will I get study-related care from a local doctor?

What studies are open now?

Senior_Female_Young_Male

Talk to a Meridian Enrollment Specialist...

Midwest

(402) 934-7563

Mon.-Fri., 8 a.m.-7 p.m.; Sat. 9 a.m.-Noon (CT)

South and East Coast

(912) 623-2240

Mon.-Th., 8 a.m.-7 p.m.; Fri., 8 a.m.-5 p.m. (ET)

k+
Subjects Enrolled
+
Studies Conducted
%
Enrollment for Vaccine Trials
Years in Research

Clients and Partners

Meridian provides Phase I-IV research services for Sponsors and CROs developing drugs, medical devices, and diagnostics across numerous therapeutic areas.

Amgen, Abbvie, Abbott, AstraZeneca, Bayer, Bristol-Meyers Squibb, Dermira, Genentech, GlaxcoSmithKline, Johnson and Johnson, Medicago, Merck, Moderna, Novartis, NovoNordisk, Pfizer, Regeneron. Sanofi Pasteur. Seqirus, Takeda

News

Ingrid Loma-Miller, MD, Selected to Serve on National Medical Advisory Committee for National Multiple Sclerosis Society

March 4, 2019

Norfolk, Va., March, 4, 2019 — Ingrid Loma-Miller, MD, has been selected to serve on the National Medical Advisory Committee for the National Multiple Sclerosis Society (NMSS). She is a principal investigator at Meridian Clinical … Read more

Keith Vrbicky, MD, Named Faith Regional’s 2018 Physician of the Year

February 27, 2019

Congratulations to Keith Vrbicky, MD! ? He was named Faith Regional’s 2018 Physician of the Year. Charles Harper, MD, a Meridian principal investigator, was also recognized for 10 years of service at Faith Regional. Read … Read more

Recap: Meridian Good Deeds Day 2018

January 3, 2019

For 2018’s Good Deeds Day, employees at each Meridian site were given a cash stipend and a simple instruction: Go into your community and make a difference. We were blown away by the thoughtfulness with … Read more

Positive Results Announced for Phase III Clinical Trial of Evofem Hormone-Free Birth Control Product; Meridian Site Involved

December 18, 2018

Evofem Biosciences, Inc. (NASDAQ: EVFM) (“Evofem” or the “Company”) today announced that its Phase 3 clinical trial of Amphora® for the prevention of pregnancy, AMPOWER, successfully met its primary endpoint. AMPOWER assessed the efficacy, safety … Read more